Skip to content

Menu

Sheppard, Mullin, Richter & Hampton LLP logo
HomePracticeContact

FDA Law Update

Current Issues Affecting FDA-Regulated Companies

Investigational Drugs

Subscribe to Investigational Drugs
FDA-Blog-Image-Prescriptions-2-660x283

Charging for Investigational Drugs Under an IND Questions and Answers, Draft Guidance for Industry, August 2022

By Dominick DiSabatino & Eve Costopoulos on August 30, 2022
Posted in FDA

Providing further clarification to drug manufacturers about specific costs that can be charged for investigational drugs used in clinical and expanded access trials.…

Continue Reading Charging for Investigational Drugs Under an IND Questions and Answers, Draft Guidance for Industry, August 2022

Subscribe
Sheppard Mullin Blogs
Podcasts

Stay Connected

Subscribe to this blog via RSS LinkedIn Twitter Facebook

Topics

Topics

Archives

Recent Upates

  • FDA Clarifies Labeling Expectations for Prescription Drug Use-Related Software
  • Context is Key: FDA Sends a Strong Message About Efficacy Claims
  • FDA’s Office of Prescription Drug Promotion Issues Second Untitled Letter of the Year to Exeltis for Misleading Statements Relating to SLYND®
  • FDA Approves First Over-the-Counter Daily Oral Contraceptive
  • FDA Maintains Focus on “Intended Use” for Software-Enabled Medical Devices

Sheppard Mullin Blogs

  • Antitrust Law Blog
  • Art Law Blog
  • Cannabis Law Blog
  • China Law Update Blog
  • Class Action Defense Strategy Blog
  • Construction & Infrastructure Law Blog
  • Consumer Finance and Fintech Blog
  • Corporate & Securities Law Blog
  • Covering Your Ads Blog
  • Energy Law Blog
  • Entertainment Law Blog
  • Executive Compensation Law Blog
  • Eye on Privacy Blog
  • FCC Law Blog
  • FDA Law Blog
  • Finance & Bankruptcy Law Blog
  • French Desk: U.S. Legal Insights for French Businesses
  • Game Counsel
  • Global Trade Law Blog
  • Government Contracts and Investigations Blog
  • Healthcare Law Blog
  • Insurance Law Blog
  • Intellectual Property Law Blog
  • Labor & Employment Law Blog
  • Latin American Blog
  • Law of the Ledger
  • Lex Arbitri
  • New York Commercial Division Round Up Blog
  • Organizational Integrity Group Blog
  • Real Estate, Land Use & Environmental Law Blog
  • Retail Trend Spotter
  • Sheppard Mullin In The Know
  • Trade Secrets Law Blog
  • U.S. Legal Insights for Korean Businesses
  • Venture Law Blog
  • White Collar & Government Enforcement Blog

FDA Law Update

Subscribe to this blog via RSS LinkedIn Twitter Facebook
Privacy PolicyDisclaimer

About The Firm

Sheppard Mullin is a full-service Global 100 firm with more than 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, industry-leading companies have turned to Sheppard Mullin to handle corporate and technology matters, high-stakes litigation and complex financial transactions. In the U.S., the firm’s clients include more than half of the Fortune 100. For more information, please visit www.sheppardmullin.com.

Copyright © 2023, Sheppard, Mullin, Richter & Hampton LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.

Agree